However, the two groups yielded similar outcomes regarding risks for SLE, AS, scleroderma and PsA
Protecting Lean Mass During a Surplus The biggest fear lifters bring to any GLP-class peptide is muscle loss
It would not create unrestricted access, authorize every finished formulation, or mean that every customer would be a candidate for a product containing that substance
Mioduchoski, FNP-BC, Board-Certified Family Nurse Practitioner specializing in integrative wellness, medical weight loss, and anti-aging therapies Worried about the potential risks and side effects of peptide therapy
A commenter noted that utilizing FDA's existing regulatory paths and associated compliance activities avoids unnecessary duplication of product assessment resources
Experts note that patients on GLP-1 medications like Ozempic often "reduce water intake due to a feeling of fullness," which can predispose them to constipation